Mesa Laboratories, Inc. announced a quarterly dividend of $0.16 per share, payable on March 17, 2025, to shareholders recorded by February 28, 2025. The company is recognized for its leadership in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, ...

Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $141.17. The stock’s 50 day moving average price is $120.47 and its 200 day moving average price is $116.30.

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) shares were down 3.1% during trading on Tuesday .The stock traded as low as $131.21 and last traded at $131.25. Approximately 17,514 ...

LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a ...

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and ...

For more information about the Company, please visit its website at CONTACT: CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000 ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Mesa Laboratories, Inc. (MLAB) current and estimated P/E ratio data provided by Seeking Alpha.